Joe Kiani, CEO of Masimo, a medical technology company, recently gave an interview to Bloomberg TV regarding the company’s lawsuit against Apple, alleging patent infringement by the Apple Watch. Following this, the International Trade Commission (ITC) issued a ban on the import of Apple Watch for sale in the United States, prompting Apple to halt sales before the order takes effect on December 25th.
Kiani expressed skepticism about Apple’s attempts to modify the software of the Apple Watch to avoid patent issues. He believes that it is unlikely to be successful, as the company’s patents are not related to software. He also disclosed that there have been no discussions between Masimo and Apple since 2013, when Apple approached them for a potential acquisition or collaboration to develop a blood oxygen level sensor for the Apple Watch. Regarding a possible settlement, Kiani stated that Masimo would consider an offer from Apple for damages, but did not disclose a specific amount. Additionally, he expressed the company’s desire for an apology from Apple.
The ITC’s order banning the import of Apple Watch for sale in the United States currently has a deadline of December 25th, during which the President has the authority to intervene and halt the order.
TLDR: Masimo’s CEO, Joe Kiani, discusses the patent lawsuit against Apple regarding the Apple Watch and the subsequent ban imposed by the ITC. Kiani expresses doubts about Apple’s software modifications and reveals that there have been no discussions between the two companies since 2013. Masimo may accept a settlement offer from Apple for damages and desires an apology. The ban on selling Apple Watch in the US has a deadline of December 25th, which can be halted by the President.
Leave a Comment